New CML drug asciminib under Real-World study

NCT ID NCT07549516

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is watching how well asciminib works and how safe it is in adults with a type of blood cancer called chronic myeloid leukemia. It includes people who are newly diagnosed or have already tried one other treatment. The main goal is to see how many patients reach a very low level of cancer cells after 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic myelogenous leukemia, BCR-ABL1 positive Leukemia, Myelogenous, Chronic, BCR-ABL Positive

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LEUKEMIA, CHRONIC MYELOID

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Locations

Novartis Investigative Site
RECRUITING

Augsburg, Bavaria, 86152, Germany
Novartis Investigative Site
RECRUITING

Herrsching am Ammersee, Bavaria, 82211, Germany
Novartis Investigative Site
RECRUITING

Kempten (Allgäu), Bavaria, 87439, Germany
Novartis Investigative Site
RECRUITING

Munich, Bavaria, 81241, Germany
Novartis Investigative Site
RECRUITING

Bremerhaven, Free Hanseatic City of Bremen, 27576, Germany
Novartis Investigative Site
RECRUITING

Offenbach, Hesse, 63065, Germany
Novartis Investigative Site
RECRUITING

Cologne, North Rhine-Westphalia, 50674, Germany
Novartis Investigative Site
RECRUITING

Cologne, North Rhine-Westphalia, 50677, Germany
Novartis Investigative Site
RECRUITING

Zittau, Saxony, 02763, Germany
Novartis Investigative Site
RECRUITING

Merseburg, Saxony-Anhalt, 06217, Germany
Novartis Investigative Site
RECRUITING

Oldenburg in Holstein, Schleswig-Holstein, 23758, Germany
Novartis Investigative Site
RECRUITING

Saalfeld, Thuringia, 07318, Germany
Novartis Investigative Site
RECRUITING

Bad Liebenwerda, 04924, Germany
Novartis Investigative Site
RECRUITING

Berlin, 12487, Germany
Novartis Investigative Site
RECRUITING

Buchholz Nordheide, 21244, Germany
Novartis Investigative Site
RECRUITING

Cottbus, 03046, Germany
Novartis Investigative Site
RECRUITING

Detmold, 32756, Germany
Novartis Investigative Site
RECRUITING

Dorfen, 84405, Germany
Novartis Investigative Site
RECRUITING

Dresden, 01307, Germany
Novartis Investigative Site
RECRUITING

Düren, 52353, Germany
Novartis Investigative Site
RECRUITING

Hanover, 30161, Germany
Novartis Investigative Site
RECRUITING

Hanover, 30625, Germany
Novartis Investigative Site
RECRUITING

Naunhof, 04683, Germany
Novartis Investigative Site
RECRUITING

Neuss, 41462, Germany
Novartis Investigative Site
RECRUITING

Parchim, 19370, Germany
Novartis Investigative Site
RECRUITING

Potsdam, 14467, Germany
Novartis Investigative Site
RECRUITING

Schorndorf, 73614, Germany
Novartis Investigative Site
RECRUITING

Soest, 59494, Germany
Novartis Investigative Site
RECRUITING

Stade, 21680, Germany